Related Experiment Video
Updated: Jan 12, 2026

07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
7.3K
Real-World Adherence to Repeat Colorectal Cancer Screening With the Multi-Target Stool DNA Test in a Large, Insured,
Mallik Greene1, Joseph Anderson2, Joseph LeMaster3
1Exact Sciences Corporation, Madison, Wisconsin, USA.
Cancer Medicine
|October 30, 2025
Summary
Adherence to repeat colorectal cancer (CRC) screening using the multi-target stool DNA (mt-sDNA) test was high in a large US study. This non-invasive test shows promise for improving CRC screening rates.
Area of Science:
- Oncology
- Gastroenterology
- Public Health
Background:
- Current US colorectal cancer (CRC) screening rates are suboptimal despite guidelines recommending screening initiation at age 45.
- The non-invasive multi-target stool DNA (mt-sDNA) test offers an alternative for CRC screening.
- Adherence to recommended screening intervals is crucial for effective CRC prevention.
Purpose of the Study:
- To evaluate adherence to repeat CRC screening using the mt-sDNA test in average-risk US adults.
- To identify factors associated with adherence to repeat mt-sDNA screening.
- To assess follow-up colonoscopy rates after positive mt-sDNA screening tests.
Main Methods:
- Retrospective claims-based analysis of 352,253 individuals aged 45-75 years at average CRC risk.
- Included individuals who previously completed an mt-sDNA test and received a repeat kit via point-of-care order.
- Primary outcome was adherence (return of a valid kit within 1 year); secondary outcomes included follow-up colonoscopy rates.
Main Results:
- Overall adherence for repeat mt-sDNA screening was 86.2%.
- Higher household income and receipt of digital outreach were associated with increased adherence.
- Among patients with a positive test, 75.8% completed follow-up colonoscopy.
Conclusions:
- High adherence to repeat screening with the mt-sDNA test was observed in a real-world setting.
- The mt-sDNA test demonstrates effectiveness in enhancing CRC screening adherence.
- These findings support the utility of the mt-sDNA test in improving population-level CRC screening coverage.

